ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 124 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $348,598 | -3.2% | 235,539 | +5.3% | 0.00% | – |
| Q2 2023 | $360,168 | -51.7% | 223,707 | -13.0% | 0.00% | – |
| Q1 2023 | $745,584 | +71.5% | 257,098 | +94.0% | 0.00% | – |
| Q4 2022 | $434,669 | -46.8% | 132,521 | -38.7% | 0.00% | – |
| Q3 2022 | $817,000 | -98.2% | 216,118 | -96.3% | 0.00% | -100.0% |
| Q2 2022 | $45,541,000 | -14.7% | 5,846,060 | +1.7% | 0.01% | +25.0% |
| Q1 2022 | $53,387,000 | -39.7% | 5,746,740 | +2.4% | 0.00% | -42.9% |
| Q4 2021 | $88,465,000 | +10.3% | 5,613,242 | +25.2% | 0.01% | +16.7% |
| Q3 2021 | $80,238,000 | +258.9% | 4,482,546 | +211.8% | 0.01% | +200.0% |
| Q2 2021 | $22,357,000 | -9.0% | 1,437,772 | -16.0% | 0.00% | 0.0% |
| Q1 2021 | $24,581,000 | -30.6% | 1,711,795 | -5.1% | 0.00% | -33.3% |
| Q4 2020 | $35,412,000 | +36.9% | 1,803,995 | -9.6% | 0.00% | 0.0% |
| Q3 2020 | $25,873,000 | -11.7% | 1,996,373 | -0.8% | 0.00% | 0.0% |
| Q2 2020 | $29,309,000 | +411.6% | 2,011,580 | +198.8% | 0.00% | +200.0% |
| Q1 2020 | $5,729,000 | -48.4% | 673,185 | -0.2% | 0.00% | 0.0% |
| Q4 2019 | $11,112,000 | -48.1% | 674,690 | -55.5% | 0.00% | -66.7% |
| Q3 2019 | $21,394,000 | -76.4% | 1,515,125 | -66.4% | 0.00% | -72.7% |
| Q2 2019 | $90,795,000 | -64.4% | 4,514,863 | -29.7% | 0.01% | -64.5% |
| Q1 2019 | $255,114,000 | +39.2% | 6,417,956 | +21.7% | 0.03% | +24.0% |
| Q4 2018 | $183,225,000 | -14.5% | 5,274,169 | +1.8% | 0.02% | +4.2% |
| Q3 2018 | $214,224,000 | -5.0% | 5,180,737 | -15.5% | 0.02% | -7.7% |
| Q2 2018 | $225,440,000 | -6.7% | 6,134,427 | -1.0% | 0.03% | -10.3% |
| Q1 2018 | $241,666,000 | +628.1% | 6,196,562 | +237.9% | 0.03% | +625.0% |
| Q4 2017 | $33,193,000 | +11.2% | 1,833,868 | +1.7% | 0.00% | 0.0% |
| Q3 2017 | $29,842,000 | +11.8% | 1,803,168 | -5.4% | 0.00% | +33.3% |
| Q2 2017 | $26,689,000 | -33.9% | 1,906,368 | -3.0% | 0.00% | -40.0% |
| Q1 2017 | $40,397,000 | +2.2% | 1,965,768 | -29.4% | 0.01% | 0.0% |
| Q4 2016 | $39,512,000 | -47.7% | 2,782,447 | -21.3% | 0.01% | -50.0% |
| Q3 2016 | $75,601,000 | +7.5% | 3,534,403 | +13.1% | 0.01% | 0.0% |
| Q2 2016 | $70,353,000 | +53.7% | 3,125,407 | +29.9% | 0.01% | +66.7% |
| Q1 2016 | $45,769,000 | -16.9% | 2,405,094 | +15.3% | 0.01% | -14.3% |
| Q4 2015 | $55,086,000 | +9.2% | 2,085,790 | +30.0% | 0.01% | 0.0% |
| Q3 2015 | $50,432,000 | -4.2% | 1,604,081 | +60.7% | 0.01% | 0.0% |
| Q2 2015 | $52,652,000 | +82.5% | 997,959 | +43.8% | 0.01% | +75.0% |
| Q1 2015 | $28,843,000 | -20.0% | 693,833 | -48.5% | 0.00% | -20.0% |
| Q4 2014 | $36,059,000 | – | 1,348,015 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
| Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
| Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
| BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
| Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
| MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
| Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
| Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |